Back to Index
George Yaghmour
Assistant Professor of Clinical Medicine
NOR 1441 Eastlake Ave Health Sciences Campus Los Angeles


George Yaghmour, MD has joined the Jane Anne Nohl Division of Hematology as Assistant Professor of Clinical Medicine. Dr. Yaghmour will be working specifically in the areas of Acute Leukemia and Allogeneic Stem Cell Transplantation. He graduated from University of Aleppo, Syria. He performed his residency training in Internal Medicine at Henry Ford Hospital/Wayne State University and then joined University of Tennessee Health Sciences Center/West Cancer Center in Memphis, TN for a clinical fellowship in Hematology and Medical Oncology. He is board certified in Internal Medicine, Hospital Medicine, Hematology and Medical Oncology.


Tennessee Oncology Practice Society: Outstanding Fellow Award, 2015

Asheville Hematologic Malignancies Symposium: Scholarship Award, 2015

VAMC Memphis: Star Team Award, 2014

Wayne State University, Henry Ford Hospital : Recognized and Ranked Top 5% Internal Medicine Residents, 2013

Henry Ford Hospital: Outstanding Patient Satisfaction/ Care, 2012

Aleppo University School of Medicine: Top 1% Graduate Award, 2008


Sweet's syndrome associated with clonal hematopoiesis of indeterminate potential responsive to 5-azacitidine. Ther Adv Hematol. 2017 Feb; 8(2):91-95. View in: PubMed

Addition of Rituximab to Chemotherapy Reduced the Rate of Surgery for Gastric-DLBCL Without Increasing Early Mortality. Anticancer Res. 2017 02; 37(2):813-817. View in: PubMed

Under-recognition of hemophagocytic syndrome in United States' rural, non-teaching hospitals. Leuk Lymphoma. 2016 Dec; 57(12):2911-2913. View in: PubMed

Role of Genomic Instability in Immunotherapy with Checkpoint Inhibitors. Anticancer Res. 2016 Aug; 36(8):4033-8. View in: PubMed

Genomic landscape of small cell carcinoma of the breast contrasted to small cell carcinoma of the lung. Breast Cancer Res Treat. 2016 Jul; 158(1):195-202. View in: PubMed

Comorbidities Drive Outcomes for Both Malignancy-Associated and Non-Malignancy-Associated Hemophagocytic Syndrome. Clin Lymphoma Myeloma Leuk. 2016 Apr; 16(4):230-6. View in: PubMed

Genomic alterations in neuroendocrine cancers of the ovary. J Ovarian Res. 2016; 9(1):52. View in: PubMed

How Center Volumes Affect Early Outcomes in Acute Myeloid Leukemia. Clin Lymphoma Myeloma Leuk. 2015 Nov; 15(11):646-54. View in: PubMed

Population-based Analysis of the Clinical Features of Primary Small Cell Carcinoma of the Ovary. Anticancer Res. 2015 May; 35(5):3091-5. View in: PubMed

Early mortality in acute myeloid leukemia. Leuk Res. 2015 May; 39(5):505-9. View in: PubMed

Ibrutinib has some activity in Richter's syndrome. Blood Cancer J. 2015; 5:e277. View in: PubMed

All that glitters is not gold: differential diagnosis of clover-leaf lymphocytes. Int J Hematol. 2013 Jun; 97(6):679-80. View in: PubMed

Powered bySC CTSI